Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
187
NMPA:187
Drug Approvals
Diprophylline Injection
- Product Name
- 二羟丙茶碱注射液
- Approval Number
- 国药准字H20253989
- Approval Date
- Apr 22, 2025
NMPA
Dexamethasone Sodium Phosphate Injection
- Product Name
- 地塞米松磷酸钠注射液
- Approval Number
- 国药准字H20253844
- Approval Date
- Apr 8, 2025
NMPA
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20253323
- Approval Date
- Jan 24, 2025
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H20247278
- Approval Date
- Nov 7, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20244669
- Approval Date
- Aug 20, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20244478
- Approval Date
- Jul 22, 2024
NMPA
lincomycin Hydrochloride Eye Drops
- Product Name
- 盐酸林可霉素滴眼液
- Approval Number
- 国药准字H51023706
- Approval Date
- Jun 14, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
Clinical Trials
No trials found
News
No news found